Orum Therapeutics, Inc. (KOSDAQ:475830)
126,300
+1,400 (1.12%)
At close: Mar 20, 2026
403.19% (1Y)
| Market Cap | 2.68T +279.6% |
| Revenue (ttm) | 25.48M -100.0% |
| Net Income | -36.88B |
| EPS | -2,048.17 |
| Shares Out | 21.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 419,508 |
| Average Volume | 388,707 |
| Open | 127,700 |
| Previous Close | 124,900 |
| Day's Range | 122,600 - 129,200 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 52.46 |
| Earnings Date | Mar 27, 2026 |